Guilherme Diogo Silva

Is there a role for off‐label high‐efficacy disease‐modifying drugs in progressive multiple sclerosis? A network meta‐analysis

D. Callegaro, S. ApÓstolos-Pereira, Guilherme Diogo Silva, 2022, Acta neurologica Scandinavica.

A critical review and update on autoimmune encephalitis: understanding the alphabet soup

M. Simabukuro, Luiz Henrique Martins Castro, L. Lucato, 2022, Arquivos de Neuro-Psiquiatria.

Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, Brazil.

D. Callegaro, Guilherme Diogo Silva, S. Apóstolos-Pereira, 2022, Multiple sclerosis and related disorders.

Paracentral Acute Middle Maculopathy Associated with Severe Anti-Mog (Myelin Oligodendrocyte Glycoprotein)-Positive Optic Neuritis

M. Monteiro, D. Callegaro, L. Lucato, 2023, Neuro-ophthalmology.

Cost, efficacy, and safety comparison between early intensive and escalating strategies for multiple sclerosis: A systematic review and meta-analysis.

D. Callegaro, R. Nascimento, Leonardo Zumerkorn Pipek, 2023, Multiple sclerosis and related disorders.

Risk and characteristics of attacks occurring after vaccination in patients with neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.

Guilherme Diogo Silva, Paula Baleeiro Rodrigues Silva, 2023, Multiple Sclerosis and Related Disorders.

Prophylactic antiseizure drugs for spontaneous intracerebral hemorrhage: An updated systematic review and meta-analysis

E. Figueiredo, Guilherme Diogo Silva, Rebeka Bustamante Rocha, 2022, International journal of stroke : official journal of the International Stroke Society.

Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.

D. Callegaro, T. Adoni, J. V. Mahler, 2024, Multiple sclerosis and related disorders.